Compositions and methods for assessing acute rejection in renal transplantation
A technology for kidney transplantation and biological samples, applied in the field of compositions and methods for evaluating acute rejection in kidney transplantation, capable of solving the problems of lack of sensitive, specific and non-invasive detection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0134] Example 1: Study Design for Development of Compositions and Methods for Assessing Acute Rejection of Kidney Transplantation
[0135] The Assessing Acute Rejection of Kidney Transplantation (AART) study was designed as a collaborative effort of 8 kidney transplant centers around the world, using 558 peripheral blood (PB) samples from 438 adult and pediatric kidney transplant patients to develop A simple blood QPCR assay for the diagnosis and prediction of acute rejection (AR) in recipients of different immunosuppressed states and transplant center-specific procedures.
[0136] figure 1 The study design for acute assessment of renal transplant rejection (AART) in 438 independent adult / pediatric renal transplant patients from 8 transplant centers worldwide is described. Emory, UCLA, UPMC, CPMC, UCSF, and Barcelona provided adult samples, and Mexico and Stanford provided pediatric samples. For AR QPCR analysis, samples were divided into 4 cohorts: cohort 1 n = 143 adult s...
Embodiment 2
[0145] Example 2: Blood samples
[0146] Peripheral blood samples from separate pediatric (recipient age at transplant = 0.8-21.9 years; n = 200) and adult (recipient age at transplant = 23-78 years; n = 315) kidney transplant recipients (n = 518 ) was used to develop a universal peripheral blood gene panel for the noninvasive diagnosis of biopsy-determined acute renal transplant rejection. Of the 200 samples in the pediatric cohort, 177 samples were previously obtained as part of an NIH / NIAID-funded prospective multicenter clinical trial recruiting with and without histology from 12 transplant centers in the United States Patients with grade AR (SNS01; NCT00141037; www.Clinical Trials.gov; Li, L., et al. Am. J. Transplant. 2012, 12, 2710-2718). The remaining 23 samples were obtained exclusively for this study from the Nephrology Research Laboratory of the Hospital for Infantiles and Children of Mexico. Of the 315 samples in the adult cohort, samples were obtained from six t...
Embodiment 3
[0148] Example 3: Patient
[0149] Adult and Pediatric Set I
[0150] Table 5 shows Adult and Pediatric Set I.
[0151] In one example, combined pediatric and adult samples were split into two groups for testing (n=236; 143 adult, 93 pediatric) and validation (n=292; 208 adult, 84 pediatric, Table 5) .
[0152] Adult and Pediatric Episode II
[0153] In another example, the combined pediatric and adult samples were split into three groups for training and testing (n=143 adult), validation (n=124; 59 adult, 65 pediatric) and independent prediction (n=143 adult). 191; 130 adults and 61 pediatrics, Table 4).
[0154] Adult and Pediatric Episode III
[0155] In another example, the combined pediatric and adult samples were divided into 100 samples for validation (77 adult, 23 pediatric, Table 4).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com